This issue of PET Clinics focuses on Evolving Role of PET-guided Interventional Oncology Based Procedures, and is edited by Drs. Abass Alavi (the Consulting Editor of PET Clinics), Marnix Lam, Stephen Hunt, and Ghassan El-Haddad. Articles will include: Y-90 PET/CT and radioembolization; FDG-PET and radioembolization; Ga-68-PSMA PET and HCC; C11 Acetate-PET for hepatocellular carcinoma patients undergoing radioembolization; FDG-PET for Ablation Treatment Planning, Intraprocedural Monitoring and Response; Global FDG Response Assessment to IR Procedures with Concomitant Immunotherapy; PET Assessment of Abscopal Effects and Pseudoprogression from IR Procedures; FDG-PET for monitoring response to embolotherapy (TACE) in primary and metastatic liver disease; and more!
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. ix 7. CME Accreditation Page - p. x 8. Preface - p. xiii 9. The Evolving Role of PET-Based Novel Quantitative Techniques in the Interventional Radiology Procedures of the Liver - p. 419 10. Fluorodeoxyglucose-PET for Ablation Treatment Planning, Intraprocedural Monitoring, and Response - p. 427 11. Fluorodeoxyglucose PET for Monitoring Response to Embolotherapy (Transarterial Chemoembolization) in Primary and Metastatic Liver Tumors - p. 437 12. The Unique Role of Fluorodeoxyglucose-PET in Radioembolization - p. 447 13. Significant Value of 11C-Acetate and 18F-Fluorodeoxyglucose PET/Computed Tomography on 90Y Microsphere Radioembolization for Hepatocellular Carcinoma - p. 459 14. PET/CT Specificities in 90Y Imaging Post Radioembolization - p. 469 15. PET Assessment of Immune Effects from Interventional Oncology Procedures - p. 477 16. Prostate-Specific Membrane Antigen PET/Magnetic Resonance Imaging for the Planning of Salvage Radiotherapy in Patients with Prostate Cancer with Biochemical Recurrence After Radical Prostatectomy - p. 487
No hay muestra disponible
No hay ficha técnica disponible
This issue of PET Clinics focuses on Evolving Role of PET-guided Interventional Oncology Based Procedures, and is edited by Drs. Abass Alavi (the Consulting Editor of PET Clinics), Marnix Lam, Stephen Hunt, and Ghassan El-Haddad. Articles will include: Y-90 PET/CT and radioembolization; FDG-PET and radioembolization; Ga-68-PSMA PET and HCC; C11 Acetate-PET for hepatocellular carcinoma patients undergoing radioembolization; FDG-PET for Ablation Treatment Planning, Intraprocedural Monitoring and Response; Global FDG Response Assessment to IR Procedures with Concomitant Immunotherapy; PET Assessment of Abscopal Effects and Pseudoprogression from IR Procedures; FDG-PET for monitoring response to embolotherapy (TACE) in primary and metastatic liver disease; and more!
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. ix 7. CME Accreditation Page - p. x 8. Preface - p. xiii 9. The Evolving Role of PET-Based Novel Quantitative Techniques in the Interventional Radiology Procedures of the Liver - p. 419 10. Fluorodeoxyglucose-PET for Ablation Treatment Planning, Intraprocedural Monitoring, and Response - p. 427 11. Fluorodeoxyglucose PET for Monitoring Response to Embolotherapy (Transarterial Chemoembolization) in Primary and Metastatic Liver Tumors - p. 437 12. The Unique Role of Fluorodeoxyglucose-PET in Radioembolization - p. 447 13. Significant Value of 11C-Acetate and 18F-Fluorodeoxyglucose PET/Computed Tomography on 90Y Microsphere Radioembolization for Hepatocellular Carcinoma - p. 459 14. PET/CT Specificities in 90Y Imaging Post Radioembolization - p. 469 15. PET Assessment of Immune Effects from Interventional Oncology Procedures - p. 477 16. Prostate-Specific Membrane Antigen PET/Magnetic Resonance Imaging for the Planning of Salvage Radiotherapy in Patients with Prostate Cancer with Biochemical Recurrence After Radical Prostatectomy - p. 487
No hay muestra disponible
No hay ficha técnica disponible
